Halal Bourse

Home › Companies › Pharmaceuticals and biotechnology › France

Is MEDINCELL S.A. stock halal?

Prohibited

Thresholds exceeded under all standards, and the strict view excludes it.

This verdict follows the median view, that of AAOIFI Standard No. 21. It is based on the financial statements for the fiscal year ended 03/31/2026.

Eligible for the French PEA: company listed on a regulated market, registered office in the European Union or the European Economic Area. Confirm with your broker. Stocks in the PEA

Open the evidence file

The ratios

CriterionMeasureThresholdResult
Interest-bearing debt50.9% of total assets30%threshold exceeded
Interest-bearing investments78.4% of total assets30%threshold exceeded
Impermissible income7.2% of revenue5%threshold exceeded

Standard: Total assets, 30% threshold.

The three views

Business activity

Médicaments injectables à action prolongée (licences biopharmaceutiques)

Financial statements read

Fiscal year ended 03/31/2026, in millions of euros. Source: Annual report of MEDINCELL S.A. (ESEF format), fiscal year ended 2026-03-31.

What could not be verified

In the same sector

Compliance comparison only: no opinion on the value of these securities.

General information: neither investment advice nor a fatwa. Verdict calculated by published rules, from financial statements read automatically and not reviewed by a human. Read the methodology